Heron Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
ALKERMES USD 49.2M 12.92M 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amarin USD 16.89M 18.51M 2025-03
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
Eisai JPY 40.6B 5.33B 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Insmed USD 21.28M 4.87M 2025-03
Ligand Pharmaceuticals USD 4.85M 2.01M 2025-03
Merck USD 2.76B 944M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Veracyte USD 34.96M 4.91M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Heron Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.